Waning Effectiveness and Safety of Homologous Primary AZD1222, CoronaVac, and BNT162b2 Vaccines
Channel: Jing Lian Suah
Date: 2022-09-09

Poster pitch for "Waning Effectiveness and Safety of Homologous Primary AZD1222, CoronaVac, and BNT162b2 Vaccines in the Adult Population in Malaysia", presented at the 16th Vaccine Congress 2022, Italy.

Replication files and further details on the study can be found at https://github.com/suahjl/waningve-covid-mys-2022-expansion

Ethical Consideration
This is part of The Real-World Evaluation of COVID-19 Vaccines under the Malaysia National COVID-19 Immunization Programme (RECoVaM), and The Case-Based Monitoring of Adverse Events Following COVID-19 Vaccination (SAFECOVAC) studies registered in the National Medical Research Register (NMRR-21-1660-60697, and NMRR-21-322-59745). Ethical approvals were granted by the Medical Research and Ethics Committee (MREC), Ministry of Health, Malaysia.